Genetic polymorphisms and thromoembolic risk in atrial fibrillation

Comment

Francisco Marín et al. J Thromb Thrombolysis. 2004 Oct.

. 2004 Oct;18(2):151-2.

doi: 10.1007/s11239-004-0211-y.

No abstract available

Comment on

Factor V Leiden and risk of ischemic stroke in nonvalvular atrial fibrillation: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.
Go AS, Reed GL, Hylek EM, Phillips KA, Liu L, Henault LE, Selby JV, Singer DE. Go AS, et al. J Thromb Thrombolysis. 2003 Feb;15(1):41-6. doi: 10.1023/a:1026192301848. J Thromb Thrombolysis. 2003. PMID: 14574075
Atrial fibrillation and hypercoagulability: dependent on clinical factors or/and on genetic alterations?
Hatzinikolaou-Kotsakou E, Kartasis Z, Tziakas D, Hotidis A, Stakos D, Tsatalas K, Bourikas G, Kotsakou ME, Hatseras DI. Hatzinikolaou-Kotsakou E, et al. J Thromb Thrombolysis. 2003 Dec;16(3):155-61. doi: 10.1023/B:THRO.0000024053.45693.fc. J Thromb Thrombolysis. 2003. PMID: 15087601